LobbyingPrime Therapeutics lobbying by quarter
Prime Therapeutics's latest lobbying report covers Q3 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $490K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Prime Therapeutics
- Latest quarter
- $20K
- Q3 2026 · 1 reports
- Last 12 months
- $490K
- Last 4 quarters
- vs last quarter
- −86.7%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $120K | 3 |
| Q1 2023 | $130K | 3 |
| Q2 2023 | $130K | 3 |
| Q3 2023 | $130K | 3 |
| Q4 2023 | $130K | 3 |
| Q1 2024 | $140K | 3 |
| Q2 2024 | $150K | 3 |
| Q3 2024 | $150K | 3 |
| Q4 2024 | $150K | 3 |
| Q1 2025 | $470K | 3 |
| Q2 2025 | $150K | 3 |
| Q3 2025 | $150K | 3 |
| Q4 2025 | $150K | 3 |
| Q1 2026 | $170K | 3 |
| Q2 2026 | $150K | 3 |
| Q3 2026 | $20K | 1 |
Policy issues the reports name
- Health issues43 reports
- Medicare and Medicaid24 reports
- Pharmacy14 reports
- Trade3 reports
- Budget and appropriations2 reports
A report that names several issues counts once for each.
Who was lobbied
- SENATE44 reports
- HOUSE OF REPRESENTATIVES43 reports
- Health & Human Services, Dept of (HHS)13 reports
- Labor, Dept of (DOL)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-housePrime Therapeutics | $1.7M | 15 quarters |
| Government Counsel | $470K | 16 quarters |
| Stumptown Strategies | $300K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BLAIR LARKINS | Staff Assistant, Rep. Greg Walden (2005-2006); Executive Assistant, Rep. Greg Walden (2006-2011) | Q2 2026 |
| HENRY W MENN iii | Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner. | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/18for Q3 | Government Counsel | $20K |
| 08/13for Q3 | Red+blue Strategies | Under $5,000 |
| 07/20for Q2 | Stumptown Strategies | $20K |
| 07/17for Q2 | Government Counsel | $30K |
| 07/16for Q2 | In-house | $100K |
| 04/20for Q1 | In-house | $120K |
| 04/20for Q1 | Government Counsel | $30K |
| 04/07for Q1 | Stumptown Strategies | $20K |
| 01/20for Q4 2025 | In-house | $100K |
| 01/19for Q4 2025 | Stumptown Strategies | $20K |
| 01/19for Q4 2025 | Government Counsel | $30K |
| 25/10/20for Q3 2025 | Stumptown Strategies | $20K |
| 25/10/16for Q3 2025 | In-house | $100K |
| 25/10/02for Q3 2025 | Government Counsel | $30K |
| 25/07/21for Q2 2025 | Stumptown Strategies | $20K |
| 25/07/16for Q2 2025 | In-house | $100K |
| 25/07/09for Q2 2025 | Government Counsel | $30K |
| 25/04/21for Q1 2025 | In-house | $420K |
| 25/04/15for Q1 2025 | Government Counsel | $30K |
| 25/04/13for Q1 2025 | Stumptown Strategies | $20K |